Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1

被引:11
|
作者
Hines, Timothy J. [1 ]
Tadenev, Abigail L. D. [1 ]
Lone, Museer A. [2 ]
Hatton, Courtney L. [1 ]
Bagasrawala, Inseyah [1 ]
Stum, Morgane G. [1 ]
Miers, Kathy E. [1 ]
Hornemann, Thorsten [2 ]
Burgess, Robert W. [1 ]
机构
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[2] Univ Zurich, Inst Clin Chem, Zurich, Switzerland
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
axon degeneration; Charcot-Marie-Tooth; demyelination; HSN1; inherited peripheral neuropathy; sphingolipid synthesis; SPTLC2; tRNA synthetase; YARS; TRANSFER-RNA SYNTHETASE; SERINE PALMITOYLTRANSFERASE; MUTATIONS; SUBUNIT; SPTLC1; ACCUMULATION; TRANSFERASE; EXPRESSION; PHENOTYPE; CELLS;
D O I
10.1111/joa.13605
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Animal models of neurodegenerative diseases such as inherited peripheral neuropathies sometimes accurately recreate the pathophysiology of the human disease, and sometimes accurately recreate the genetic perturbations found in patients. Ideally, models achieve both, but this is not always possible; nonetheless, such models are informative. Here we describe two animal models of inherited peripheral neuropathy: mice with a mutation in tyrosyl tRNA-synthetase, Yars(E196K), modeling dominant intermediate Charcot-Marie-Tooth disease type C (diCMTC), and mice with a mutation in serine palmitoyltransferase long chain 1, Sptlc1(C133W), modeling hereditary sensory and autonomic neuropathy type 1 (HSAN1). Yars(E196K) mice develop disease-relevant phenotypes including reduced motor performance and reduced nerve conduction velocities by 4 months of age. Peripheral motor axons are reduced in size, but there is no reduction in axon number and plasma neurofilament light chain levels are not increased. Unlike the dominant human mutations, the Yars(E196K) mice only show these phenotypes as homozygotes, or as compound heterozygotes with a null allele, and no phenotype is observed in E196K or null heterozygotes. The Sptlc1(C133W) mice carry a knockin allele and show the anticipated increase in 1-deoxysphingolipids in circulation and in a variety of tissues. They also have mild behavioral defects consistent with HSAN1, but do not show neurophysiological defects or axon loss in peripheral nerves or in the epidermis of the hind paw or tail. Thus, despite the biochemical phenotype, the Sptlc1(C133W) mice do not show a strong neuropathy phenotype. Surprisingly, these mice were lethal as homozygotes, but the heterozygous genotype studied corresponds to the dominant genetics seen in humans. Thus, Yars(E196K) homozygous mice have a relevant phenotype, but imprecisely reproduce the human genetics, whereas the Sptlc1(C133W) mice precisely reproduce the human genetics, but do not recreate the disease phenotype. Despite these shortcomings, both models are informative and will be useful for future research.
引用
收藏
页码:1169 / 1185
页数:17
相关论文
共 50 条
  • [41] Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A
    Bjelica, Bogdan
    Peric, Stojan
    Bozovic, Ivo
    Jankovic, Milena
    Brankovic, Marija
    Palibrk, Aleksa
    Stojanovic, Vidosava Rakocevic
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1481 - 1486
  • [42] DIAPHRAGMATIC DYSFUNCTION IN SIBLINGS WITH HEREDITARY MOTOR AND SENSORY NEUROPATHY (CHARCOT-MARIE-TOOTH DISEASE)
    CHAN, CK
    MOHSENIN, V
    LOKE, J
    VIRGULTO, J
    SIPSKI, ML
    FERRANTI, R
    CHEST, 1987, 91 (04) : 567 - 570
  • [43] Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1)
    Rochat, Julie
    Blavier, Andre
    Ruet, Severine
    Vasseur, Sophie
    Puma, Angela
    Desnous, Beatrice
    Chan, Victor
    Delmont, Emilien
    Attarian, Shahram
    Morales, Raul Juntas
    Quadrio, Isabelle
    Vidoni, Leo
    Bonello-Palot, Nathalie
    Cheillan, David
    GENES, 2024, 15 (06)
  • [44] Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35
    Jordanova, A
    Thomas, FP
    Guergueltcheva, V
    Tourney, I
    Gondim, FAA
    Ishpekova, B
    De Vriendt, E
    Jacobs, A
    Litvinenko, I
    Ivanova, N
    Buzhov, B
    De Jonghe, P
    Kremensky, I
    Timmerman, V
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (06) : 1423 - 1430
  • [45] Is Dominant Intermediate - Charcot-Marie-Tooth type C disorder due to a defect in protein synthesis?
    Froelich, Clifford Anthony, Jr.
    Chaudoir, Marc W.
    Andrews, Tara
    First, Eric A.
    FASEB JOURNAL, 2009, 23
  • [46] Genetic analysis of two pedigrees with Charcot-Marie-Tooth neuropathy Type 1C.
    Street, VA
    Goldy, JD
    Golden, AS
    Tempel, BL
    Bird, TD
    Chance, PF
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 630 - 630
  • [47] MR IMAGING IN HYPERTROPHIC NEUROPATHY - A CASE OF HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE-I (CHARCOT-MARIE-TOOTH)
    CHOI, SK
    BOWERS, RP
    BUCKTHAL, PE
    CLINICAL IMAGING, 1990, 14 (03) : 204 - 207
  • [48] Coexistence of Charcot-Marie-Tooth disease type 1A and anti-MAG neuropathy
    Piscosquito, Giuseppe
    Salsano, Ettore
    Ciano, Claudia
    Palamara, Luisa
    Morbin, Michela
    Pareyson, Davide
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 185 - 188
  • [49] COEXISTENCE OF CHARCOT-MARIE-TOOTH DISEASE TYPE 1A AND ANTI-MAG NEUROPATHY
    Piscosquito, G.
    Salsano, E.
    Ciano, C.
    Palamara, L.
    Morbin, M.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 88 - 88
  • [50] Towards Improved Cell Culture Models of Type 1 Charcot-Marie-Tooth Disease
    Wilkinson, Mason
    Stefanski, Katherine
    Gowda, Pramod
    Carter, Bruce
    Sanders, Chuck
    PROTEIN SCIENCE, 2023, 32